Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management-Reference-Cited by-同舟云学术

Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management

Published:2020-04-24 Issue: Volume:11 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Chen Hengyu,Ma Xianxiong,Yang Ming,Wang Mengyi,Li Lei,Huang Tao

Funder

Innovative Research Group Project of the National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Genetics (clinical),Genetics,Molecular Medicine

Reference44 articles.

1. Clock genes and cancer development in particular in endocrine tissues.;Angelousi;Endocrine Relat. Cancer,2019

2. The cellular response to general and programmed DNA double strand breaks.;Bassing;DNA Repair.,2004

3. Targeting transcription factors in cancer.;Bhagwat;Trends Cancer,2015

4. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.;Brauckhoff;J. Hepatol.,2011

5. Surrogate variable analysis using partial least squares (SVA-PLS) in gene expression studies.;Chakraborty;Bioinformatics,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer;BMC Medical Genomics;2023-04-25

2. Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for Lung Cancer Prognosis;Disease Markers;2021-12-07

3. Establishment of a prognostic model of ten transcription factors in gastric cancer;Genomics;2021-11

4. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer;BioMed Research International;2021-07-09

5. A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation;OncoTargets and Therapy;2021-04